Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Celldex Therapeutics Inc
SWB:TCE2
Celldex Therapeutics Inc
SWB:TCE2
Price:
36.02
EUR
2.24%
Market Closed
Market Cap:
€1.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Celldex Therapeutics Inc
SWB:TCE2
|
US |
|
Kurganskaya Generiruyushchaya Kompaniya PAO
MOEX:KGKC
|
RU |
|
Bridgemarq Real Estate Services Inc
TSX:BRE
|
CA |
|
P
|
Pexip Holding ASA
DUS:4W9
|
NO |
|
AI/ML Innovations Inc
F:42FB
|
CA |
|
B
|
Blackbaud Inc
F:BNK
|
US |
|
T
|
Tin Nghia Industrial Park Development JSC
VN:TIP
|
VN |
|
Batulicin Nusantara Maritim Tbk PT
IDX:BESS
|
ID |
|
S
|
Silver Dollar Resources Inc
OTC:SLVDF
|
CA |
|
O
|
Oramed Pharmaceuticals Inc
F:OJU1
|
US |
|
G
|
Gem Diamonds Ltd
F:ZVW
|
UK |
|
Algoma Central Corp
F:ACH
|
CA |
|
A
|
Akbar Indo Makmur Stimec Tbk PT
IDX:AIMS
|
ID |
|
M
|
Mota Engil SGPS SA
DUS:M09
|
PT |
|
Antilles Gold Ltd
ASX:AAU
|
AU |
|
H
|
Hot Chili Ltd
XTSX:HCH
|
AU |
|
A
|
Aurizon Holdings Ltd
XMUN:QRL
|
AU |
|
E
|
Elementos Ltd
SWB:9EM
|
AU |
|
Elementos Ltd
OTC:ELTLF
|
AU |
|
H
|
Hanil Vacuum Co Ltd
KOSDAQ:123840
|
KR |
|
JMDC Inc
F:6JM
|
JP |
|
B
|
Bodycote PLC
F:21T
|
UK |
|
S
|
Shurgard Self Storage Ltd
F:S8V
|
GG |
|
K
|
Kyobo 15 Special Purpose Acquisition Co
KOSDAQ:465320
|
KR |
Wall St Price Targets
TCE2 Price Forecast
Based on 16 analysts
Based on 16 analysts
+60% Upside
from
€36.02
today
Celldex Therapeutics Inc (TCE2)’s 12-month stock price forecast through August 2027 has a consensus target of €57.65, implying 60% upside. The forecast is based on price targets from 16 Wall Street analysts.
TCE2 Analyst Rating
No ratings yet
No ratings yet
Celldex Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TCE2's stock price target?
Price Target
57.65
EUR
57.65
EUR
According to Wall Street analysts, the average 1-year price target for TCE2 is 57.65 EUR with a low forecast of 24.97 EUR and a high forecast of 92.72 EUR.
What is the Revenue forecast for Celldex Therapeutics Inc?
Projected CAGR
147%
147%
Over the last 13 years, the compound annual growth rate for Revenue has been -14%. The projected CAGR for the next 8 years is 147%.